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Background: The genus, Acalypha is one of the many genera in the Euphorbiaceae family. A. wilkesiana var. golden-
yellow (Muell & Arg.) syn. A. wilkesiana var. tropical tempest is a species and variety employed in traditional medicine 
for the treatment of gastrointestinal disorders, inflammations, bacterial and skin fungal infections amongst many 
others. Before now, some biological investigations had been done but very limited chemical studies have been carried 
out on the plant.  
Objectives: This study was principally done to isolate chemical compound(s) inherent in the plant and also evaluate 
their antimicrobial potential.  
Methodology: The leaves were to extracted cold with 50% ethanol and the resultant aqueous crude extract 
partitioned with butanol. Isolates obtained from the silica-gel column chromatography of the butanol fraction were 
analysed for antimicrobial activities using the hole-in agar diffusion technique. The compounds were screened for 
both antibacterial and antifungal activities using the microbes namely, B. subtilis, S. aureus, E. coli, P. aeruginosa, S. 
typhi, V. cholerae and C. albicans. 
Results:   Two compounds, designated as compounds W-1 [Rf (0.76); [n]20D (1.4333 )] and W-2 [Rf  (0.58)] were 
isolated. The structures of W-1 and W-2 have been established to be 4-ethoxy-4-oxobutanoic acid (ethyl succinate) 
and 2-ethoxy-5(hydroxymethyl)-oxalane-3,4-diol (ethyl β-riboside) respectively using the 1H NMR, 13C NMR, MS and 
IR spectral techniques. Both compounds were inactive against B. subtilis, S. aureus and E. coli. Interestingly, W-1 and 
W-2 demonstrated very minimal activity against P. aeruginosa, S. typhi and V. cholerae. However, neither gave any 
anticandidal activity. 
Conclusion: The two isolates (though generally weakly active) would serve as chemotaxonomic markers for this 
species and variety in particular and the genus, Acalypha in general. 
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1. Introduction 
Acalypha wilkesiana is named after the American 
scientist and explorer Admiral Chas Wilkes (1801-
1877) (Bailey, 1951). A. wilkesiana var. golden-yellow 
(Muell & Arg.) syn. A. wilkesiana var. tropical tempest is 
characterized by bright lime, yellow and green speckled 
leaves which add a bright punch to the environment. It 
is cultivated from cuttings as an ornamental foliage wild 
shrub in gardens, greenhouses, orchards and parks 
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(Hutchinson and Dalziel, 1958; Uphof, 1959; Burkill, 
1985; Watt and Breyer-Brandwijk, 1962).). This variety 
possesses same morphological features as red acalypha 
variety which is predominately red and mottled with 
purple colourations. Different preparations of this plant 
are employed in folklore medicine for the treatment of 
malaria, wounds, tumours, inflammations, 
gastrointestinal disorders, bacterial and skin fungal 
infections (Oliver, 1958; Oliver, 1959; Akinde and 
Odeyemi, 1987; Alade and Irobi, 1993; Bussing et al, 
1999; Ikewuchi et al, 2008). Before now, corilagin, 
geraniin, gallic acid, quercetin 3-O-rutinoside and 
kaempferol 3-O-rutinoside had been isolated from 
A.wilkesina var. red acalypha and A. hispida (Adesina et 
al, 2000) while ethyl gallate, pyrogallol, D-arabino-hex-
1-enitol and ethyl α-D-glucopyranoside had been 
obtained from A. wilkesiana var. lace-acalypha 
(Oladimeji and Igboasoiyi, 2014; Oladimeji and Udom, 
2014; Oladimeji and Johnson, 2015).  
This present study was carried out by subjecting the 
butanol fraction and sub-fractions obtained from this 
variety to column chromatography with a view to 
isolating chemical constituents therein and evaluating 
their antimicrobial potential. It is hoped that the 
obtained compounds will serve as chemotaxonomic 
markers for this species and variety in particular and 
genus, Acalypha in general. 
2. Materials and Methods 
2.1  Collection of plant material 
The fresh leaves of A. wilkesiana var. golden-yellow 
(Muell & Arg.) were collected in the month of December, 
2014 from a greenhouse facility located within the 
University of Uyo Town Campus, Uyo, Akwa Ibom State, 
Nigeria. The plant was identified at the Department of 
Botany and Ecology and Department of Pharmacognosy 
and Natural Medicine respectively, both of University of 
Uyo, Nigeria. A voucher specimen of the plant (No 
H122) was deposited in the Herbarium Unit of the 
Faculty of Pharmacy.  
The plant was dried in an oven (Gallenkamp, England) 
at 40 0C for 48 h and the resultant dried material 
powdered on an electric mill (Uniscope, England).  
2.2  Extraction and Isolation  
The dried powder (0.85 kg) was exhaustively extracted 
with 50 % EtOH (4 x 5L) at room temperature (27± 2 
0C) for 72 h. The obtained crude extract was filtered, 
concentrated in vacuo on a rotary evaporator (R205D, 
Shensung BS & T, China), weighed and stored in a 
desiccator (Monsorief, Scotland) prior to further use. 
107 g of the extract was partitioned Using (1:4) H-
2O:CH3CH2CH 2CH2OH (6 x 200 mL). The resultant 
butanol fraction was evaporated to dryness to give a 
solid green residue which later yielded the two 
compounds. The butanol fraction (11.6 g) was 
chromatographed on a silica gel 254 (Merck, Germany) 
glass column (Techmel, USA; 10 g pre-swollen in 100 % 
toluene; 3 g concentration zone + 7 g separation zone; 
16.5 x 3 cm) and eluted with a gradient of 10 % (CH3)2-
CO: toluene (60 mL), 20 % (CH3)2CO: toluene (60 mL), 
30 % (CH3)2CO: toluene (60 mL), 40 % 
(CH3)2CO:toluene (60 mL) and 50 % (CH3)2CO: toluene 
(60 mL). Fractions of 8 mL each were collected, 
monitored on silica plates (Model No 64271, Merck, 
Germany) in (CH3)2CO:toluene:H2O (10:20:1) using 
FeCl3/CH3OH and vanillin-H2 SO4 as spray reagents. 
Subsequently, fractions with similar TLC characteristics 
(Rf values, reaction with FeCl3 reagent or vanillin-H2 SO4 
spray) were bulked and three semi-pure residues coded 
C-1, C-2 and C-3 were obtained. C-1 (1.4 g, deep green) 
was purified on a much shorter glass column (9.6 x 2 
cm) isocratically with 100 % toluene (60 mL) resulting 
in 4-ethoxy-4-oxobutanoic acid (ethyl succinate) (olive 
green) coded W-1 (Rf (0.76); 65 mg). Similarly, C-2 
(1.1g, faintly greenish substance) was also cleaned on a 
short glass column using 20 % (CH3)2 CO:toluene (80 
mL) which yeilded 2-ethoxy-5(hydroxymethyl)-
oxalane-3,4-diol (ethyl β-riboside) (golden brown) W-2 
(Rf (0.58); 28 mg). C-3 (3.6 g, dirty white), a multi-
component semi-pure residue was not processed any 
further in the course of the present study.  
2.3  Structural Elucidation 
The mass spectra of the two compounds were obtained 
on Kratos MS 80 (Germany) while the infra-red analyses 
were done on Shimadzu FTIR 8400S (Japan). The 1H and 
13C NMR spectra were obtained on Bruker AC 250 
(Germany) operating 300 MHz for proton and 75 MHz 
for carbon-13 using CD3OD as solvent and TMS as 
internal standard. Efforts were made to obtain the 
refractive indices of the compounds at the wavelength 
(λ) of Na-D line (589.3 nm) and at 20.5 0C (Olaniyi, 
1989; Olaniyi and Ogungbamila, 1991; Olaniyi, 2000) 
using the WAY-15 Abbe Refractometer (England). 
2.4 Antimicrobial Sensitivity Screening     
The micro-organisms used in this study namely, Bacillus 
subtilis (NCTC 8853), Staphylococcus aureus (ATCC 
25723), Escherichia coli (ATCC 25173), Pseudomonas 
aeruginosa (ATCC 2654), Samonella typhi (NCTC 5438), 
Vibro cholerae (ATCC 25032) and Candida albicans 
(NCYC 436) were isolated from specimens of diarrheal 
stool, abscesses, necrotizing fascitis, osteomyelitis, 
urine, wounds and vaginal swabs obtained from the 
Medical Laboratory, University of Uyo Health Centre, 
Uyo. The isolates were collected in sterile bottles, 
identified and typed by convectional biochemical tests 
(Gibson and Khoury, 1986; Murray et al, 1995). These 
microbes were then refrigerated at -5 0C at the 
Microbiology and Parasitology Unit, Faculty of 
Pharmacy prior to use.  
The agar plates used were prepared by adhering to the 
manufacturer’s instructions. The media and plates were 
sterilized in an autoclave at 121°C for 15 min. The hole-
in-plate agar diffusion method was used observing 
standard procedure with Nutrient Agar-CM003, 
Mueller-Hinton-CM037 (Biotech Limited, Ipswich, 
England) and Sabouraud Dextrose Agar (Biomark, 
India) for the bacteria and fungus respectively. The 
inoculum of each micro-organism was introduced into 
each petri-dish (Pyrex, England). Cylindrical plugs were 
removed from the agar plates by means of a sterile 
cork-borer (Simax, India) to produce wells with 
diameter of approximately 6 millimetres. The wells 
were equidistant from each other and the edge of the 
plate (Washington, 1995; NCCLS, 2003). Concentrations 
of 20 mg mL-1 of crude extract, 10 mg mL-1 of butanol 
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fraction, 2 mg mL-1of W-1 and W-2 were introduced 
into the wells. Also, different concentrations of 10 µg 
mL-1 chlorampenicol (Gemini Drugs, Nigeria), 1mg mL-1 
of nystatin (Gemini Drugs, Nigeria) and 50 % methanol 
were introduced into separate wells as positive and 
negative controls respectively (Oladimeji, 1997; 
Oladimeji, 2012; Oladimeji and Igboasoiyi, 2014; 
Oladimeji and Udom, 2014; Oladimeji and Johnson, 
2015).  
The experiments were carried out in triplicates. The 
plates were labelled on the underside and left at room 
temperature for 2 h to allow for diffusion. The plates 
were then incubated at 37± 2 0C for 24 to 48 h. Zones of 
inhibition were measured in millimetres (mm) with the 
aid of a ruler. 
3.  Results and Discussion 
3.1 Processing of Extract, Fraction and Sub-
fractions 
The collection and identification of the plant was done 
by observing basic rules of phytomorphology. Also, the 
principles governing extraction and processing of 
extracts were observed, thus preventing any changes to 
the chemical composition of the crude extract (Odebiyi 
and Sofowora, 1978; Odebiyi and Sofowora, 1979). 
Previous studies on the crude extract of this plant 
revealed the presence of alkaloids, saponins, tannins, 
terpenes and cardiac glycosides while flavonoids, 
anthraquinones and cyanogenic glycosides were absent 
(Oladimeji, 1997; Oladimeji and Usifoh, 2015).   
Also, Oladimeji (1997), observed that the antibacterial 
and antifungal activities resided in the butanol fraction 
of the plant. In addition, the water/butanol partition 
extracted the largest amount of plant constituents, 
hence the choice of the butanol fraction for column 
chromatography. This exercise gave three semi-pure 
residues (C-1, C-2 and C-3) but C-1and C-2 were further 
processed, thereby yielding the isolates W-1and W-2. 
However, C-3 which showed a multi-component TLC 
profile was not processed any further.                                                                                                                             
3.2 Elucidation of Structures   
Spectroscopic data: The data were obtained thus: ES+ - 
MS on Kratos MS 80, IR on Shimadzu FTIR 8400S, 1H 
and 13C NMR on Bruker AC 250 operating 300 MHz for  
proton and 75 MHz for carbon-13 using CD3OD as 
solvent and TMS as internal standard.     
W-1: C6 H10O4; amorphous olive green solid; Rf (0.76); 
65 mg; [n]20 D  (1.4333); MS [ES+-MS] m/z (relative 
intensity): 147 [M+H]+ (0.34%) , 146 [M]+ (0.76 %), 128 
[M-H2O]+ (14.74 %), 119 [M-C2H5)]+ (0.84 %), 101 [M-
COOH]+ (100.00 %) (base peak), 84 [M-OC2H5-OH]+ 
(0.78 %), 73 [M-OC2H5-CO]+ (27.12 %), 56 [M-OC2H5-
COOH]+ (12.77 %), 55[M-OC2H5-COOH-1]+ (28.47 %), 29 
[M-COOC2H5-OC=O]+ (49.65%) and 27 [M-COOC2H5-
COOH-1]+ (21.54%);  IR [8400S-FTIR] cm-1: 719, 864 
(finger print), 1721(-C=O) and 3219 (-OH); 1H NMR δ 
(ppm): 0.98 (t) and 1.42 (q); 13C NMR δ (ppm): 19.45 
(methyl-C), 34.42 (methylene-C), 160.43 (carbonyl-C) 
and 162.59 (ester-C).  
W-2: C7H14 O5; golden brown substance; Rf (0.58); 28 
mg; MS [ES+-MS] m/z (relative intensity):178 [M]+ (0.12 
%), 147 [M-CH2OH]+ (0.67 %), 133 [M-OC2H5]+ (0.54 %), 
114 [M-OC2H5-OH-2]+ (0.25%), 101 [M-OC2H5-CH2OH-
1]+ (0.46%),  88 [M-CH2OH-2OH-25]+  (10.78%), 71 [M-
CH2OH-2OH-C2H5-13] + (48.67%), 60 [M-CH2OH-3OH-
C2H5-7]+  (100.00%) base peak), 47 [M-CH2OH-3OH-
OC2H5-4] + (40.87%); IR [8400S-FTIR] cm-1: 634, 756, 
843 (finger print) 1052 (-C-O-C), 2937 and 3376 (-OH); 
1H NMR δ (ppm): 1.26 (t), 1.47 (q) and 5.15(s); 13C NMR 
δ (ppm): 29.52 (methyl-C), 36.48 (methylene-C), 145.63 
and 146.45 (hydroxylated-C). 
Physical constants such as optical rotation, optical 
density, refractive index, melting point and boiling point 
are used in the qualitative and quantitative analyses of 
substances. Also, these parameters are employed to 
confirm the purity, identity, integrity of active 
substances and as well as monitor the progress of 
reactions (Olaniyi, 1989; Olaniyi and Ogungbamila, 
1991; Olaniyi, 2000). In this study, efforts were made to 
measure the refractive index of W-1 and W-2 at the 
wavelength (λ) of Na-D light (589.3 nm) and a 
temperature of 20.5 0C. The refractive index of a 
substance is an indication of the number, type of atoms 
and chemical groups (species) in the substance. Each 
atom or group in the substance contributes to its 
refractivity which adds eventually to the refractive 
index of the substance. Furthermore, refractive index 
can be used to monitor the progress of chromatographic 
separation by measuring the refractive indices of the 
effluent solvents employed. W-1 recorded a refractive 
index of 1.4333 which is particularly consistent with the 
literature value of 1.4328 while that of W-2 could not be 
unambiguously established because of insufficient 
amount of sample.  
The chemical structures of the compounds were 
established by a combination of spectroscopic 
techniques as highlighted above. The obtained data 
were matched with library data of organic compounds 
(Lopez-Avila, 1987), hence, W-1 and W-2 have been 
identified to be 4-ethoxy-4-oxobutanoic acid (ethyl 
succinate) and 2-ethoxy-5(hydroxymethyl)-oxalane- 
3,4-diol (ethyl β-riboside) respectively (Figure 1).  
Due to the nature of the matrices, many fragmented 
ions appeared in the MS spectra of the compounds. In 
the MS of W-1, those that could readily be identified 
include; [M]+ at m/z 146 (2.51 %) while fragments at 
119 (0.84 %), 101 (100.00 %) (base peak), 73 (27.12 
%) and 56 (12.77 %) correspond to the losses of ethyl 
group, carboxylate group, ethoxy and carbonyl units 
and ethoxy and carboxylate groups from W-1 
respectively. Other noticeable ions at 84 (0.78 %), 55 
(28.47 %), 29 (49.65%) and 27 (21.54%) are quazi-
peaks. The IR spectrum of W-1 shows diagnostic 
stretchings at 1721 and 3219 cm-1 indicating -C=O and -
OH groups respectively. Also, the obtained 1H and 13C 
NMR spectra of the compound are as expected.  
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Equally, W-2 showed numerous peaks in its MS matrix 
but the easily identifiable ions include [M]+at m/z 178 
(0.12 %), while fragments at 147 (0.67 %) and 133 
(0.54 %) represent the excisions of hydroxy methyl and 
ethoxy units from the W-2 molecule respectively. Other 
ions found in its spectrum at 114 (0.25 %), 101(0.46 
%), 88 (10.78 %), 71 (48.67 %), 60 (100.00 %) (base 
peak) and 47 (40.87 %) represent quazi-peaks. The IR 
spectrum of W-2 shows diagnostic signals at 1052, 
2937 and 3376 cm-1 representing -C-O-C (ether linkage) 
and -OH functional groups respectively. Also, the 1H and 
13C NMR spectra of W-2 are consistent with literature 
values.   
 
     Figure 1: Structures of W-1 and W-2 
 
Table: Results of antimicrobial screening of crude extract, butanol fraction, W-1 and W-2 at different concentrations 
on test microbes in 50 % MeOH 
 Zones of inhibition (mm) 
Test microbe 
CE 
20 mg/mL 
BT 
10 mg/mL 
W-1 
2 mg/mL 
W-2 
2 mg/mL 
50 % 
MeOH 
CP 
10 µg/mL 
NY 
1mg/mL 
B. subtilis 
(NCTC 8853) 
6 6 6 6 6 34 6 
S. aureus 
(ATCC 25723) 
6 6 6 6 6 35 6 
E. coli (ATCC 
25173) 
6 6 6 6 6 36 6 
P. aeriginosa 
(ATCC 26154) 
7.6 7.8 7.8 7.8 6 31 6 
S. typhi (NCTC 
5438) 
6 6 7.3 7.5 6 28 6 
V. cholerae 
(ATCC 25032) 
6 6 7.8 7.7 6 38 6 
C. albicans 
(NCYC 46) 
6 6 6 6 6 6 39 
Key: The zone diameter recorded is zone of inhibition + size of cup (zone of inhibition +6) mm; 
         CE = Crude ethanolic extract; BT = Butanol fraction; CP = Chloramphenicol; NY =Nystatin; 
          W-1 = 4-ethoxy-4-oxobutanoic acid (ethyl succinate); 
          W-2 = 2-ethoxy-5(hydroxymethyl)-oxalane, 3,4-diol (ethyl β-riboside);                                  
          NCTC - National Collection of Type Cultures, UK.  
          NCYC- National Collection of Yeast Cultures, UK.  
          ATCC- American Type Culture Collection, Washington, DC. 
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3.3 Antimicrobial Tests 
The microbes employed in the sensitivity tests reflected 
the entire antimicobial spectrum encompassing gram 
positive, gram negative and fungal strains. The results 
displayed in Table 1 show that both the crude extract 
and butanol fraction (which was supposed to be 
relatively purer than the former) were largely inactive 
against the micro-organisms except P. aeruginosa. 
Furthermore, W-1 and W-2 recorded no activity against 
B. subtilis, S. aureus and E. coli while the two compounds 
demonstrated very minimal activity against P. 
aeruginosa, S. typhi and V. cholerae.  
The activities given by especially the gram negative 
bacteria such as P. aeruginosa were not surprising 
because these bacteria are well known for their unique 
resistance to antimicrobial agents. This resistance is 
believed to be due to the nature of the cell envelope of 
these organisms which unlike gram positive organisms, 
possess a sophisticated three-layered envelope which 
does not allow permeation of external agents (Brown, 
1975).   
Also, both compounds demonstrated no antifungal 
activity against C. albicans. This particular observation 
was not surprising because fungal strains such as 
Candida spp. limit the permeation of substances because 
of their integral structures which are pleomorphic and 
facultative in nature hence, resembling those of higher 
plants (Brown, 1975). 
4. Conclusion 
This study reports for the first time the isolation of 4-
ethoxy-4-oxobutanoic acid (ethyl succinate) and 2-
ethoxy-5(hydroxymethyl)-oxalane-3,4-diol (ethyl β-
riboside) from the butanol fraction of the A. wilkesiana 
var. golden-yellow. These compounds are expected to 
serve as chemotaxonomic markers for the species and 
variety in particular and the genus, Acalypha in general. 
However, both compounds were generally inactive 
against microbes employed. 
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